In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fucithalmic Drug Master File in Korea (Fucithalmic KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fucithalmic. The MFDS reviews the Fucithalmic KDMF as part of the drug registration process and uses the information provided in the Fucithalmic KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fucithalmic KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fucithalmic API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fucithalmic suppliers with KDMF on PharmaCompass.